You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科興製藥(688136.SH)業績快報:2021年度淨利潤降35.16%至9021.06萬元
格隆匯 02-28 00:29

格隆匯2月28日丨科興製藥(688136.SH)發佈2021年度業績快報,實現營業收入12.85億元,同比增加5.31%;歸屬於母公司所有者的淨利潤9021.06萬元,同比下降35.16%;歸屬於母公司所有者的扣除非經常性損益的淨利潤3664.42萬元,同比下降73.40%;基本每股收益0.45元。

營業利潤、利潤總額、歸屬於母公司所有者的淨利潤、歸屬於母公司所有者的扣除非經常性損益的淨利潤同比變動幅度較大,主要原因為:報吿期公司加大研發投入,積極開展研發活動,研發費用較去年同期大幅增加;為助力公司高質量發展引進優秀管理和技術人才,人力成本同比增加;報吿期公司夯實產品銷售渠道,對終端實施精細化管理和廣覆蓋,銷售費用增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account